HLS Therapeutics (HLTRF) Q2 2024 Earnings

May 9Confirmed
May 2022
Aug 2022
Nov 2022
Q2 2024
-0.28
-0.21
-0.14
-0.07

Details

Expected EPS
-0.1587
Actual EPS
-0.19
Surprise EPS
-0.03
Surprise Percent
-19.72%

Description

⁨HLS Therapeutics⁩ (⁦HLTRF⁩) has reported earnings of ⁦-0.19⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts